New CME Activity: Rethinking Ocular Antiinfectives, Issue 4

by OphthalmologyWeb • 2011/01/04 • 0 Comments

Featured Article

← Stem Cells in Ophthalmology Update 4: ACT Receives FDA Approval to Use hESCs to Treat Dry AMD

STAAR Surgical’s Visian® ICL Surpasses 200,000 Implants →